Proteasome inhibition attenuates nitric oxide synthase expression, VCAM- 1 transcription and the development of chronic colitis

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 3, 1997, Pages 1615-1622

  Conner, Elaine M ^a   Brand, Stephen ^b   Davis, Jonathan M ^a   Laroux, F Stephen ^a   Palombella, Vito J ^b   Fuseler, John W ^a   Kang, David Y ^a   Wolf, Robert E ^a   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b ProScript Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; NITRIC OXIDE SYNTHASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; DRUG EFFECT; ENZYME REGULATION; FEMALE; GENE EXPRESSION REGULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINASE INHIBITION; RAT;

ANIMALS; CHRONIC DISEASE; CROHN DISEASE; CYSTEINE ENDOPEPTIDASES; FEMALE; GENE EXPRESSION REGULATION; MULTIENZYME COMPLEXES; NF-KAPPA B; NITRIC OXIDE SYNTHASE; PEPTIDOGLYCAN; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, INBRED LEW; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030885492     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. ADAMS, J. AND STEIN, R.: Novel inhibitors of the proteasome and their therapeutic uses in inflammation. Annu. Rep. Med. Chem. 31: 279-288, 1996.
2. ADCOCK, I. M., BROWN, C. R., KWON, O. AND BARNES, P. J.: Oxidative stress induced NFκB binding and inducible NOS mRNA in human epithelial cells. Biochem. Biophys. Res. Commun. 199: 1518-1524, 1994.
3. AIKO, S. AND GRISHAM, M. B.: Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology 109: 142-150, 1995.
4. AIKO, S., CONNER, E. M., FUSELER, J. W. AND GRISHAM, M. B.: Effects of cyclosporine or FK506 in chronic colitis. J. Pharmacol. Exp. Ther. 280: 1075-1084, 1997.
5. AIKO, S. AND GRISHAM, M. B.: Effects of nitric oxide synthase inhibition and sulfasalazine on the spontaneous intestinal inflammation observed in HLA-B27 transgenic rats. Gastroenterology 110: A852, 1996.
6. BAEUERLE, P. A. AND BALTIMORE, D.: IκB: A specific inhibitor of the NFκB transcription factor. Science 242: 540-546, 1988.
7. BAEUERLE, P. A. AND HENKLE, T.: Function and activation of NFκB in the immune system. Annu. Rev. Immunol. 12: 141-179, 1994.
8. BEAUVAIS, F., MICHEL, L. AND DUBERTRET, L.: Exogenous nitric oxide elicits chemotaxis of neutrophils in vitro. J. Cell Physiol. 165: 610-614, 1995.
9. BEG, A. A., FINCO, T. S., NANTERMET, P. V. AND BALDWIN, A. S.: Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκB: A mechanism for NFκB activation. Mol. Cell. Biol. 13: 3301-3310, 1993.
10. + Th1-like responses. J. Clin. Invest. 98: 1010-1020, 1996.
11. BOUGHTON-SMITH, N. K., EVANS, S. M., HAWKEY, C. J., COLE, A. T., BALSITIS, M., WHITTLE, B. J. AND MONCADA, S.: Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 342: 338-340, 1993.
12. BROWN, K., GERSTBERGER, S., CARLSON, L., FRANZOSO, G. AND SIEBENLIST, U.: Control of IκB proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488, 1995.
13. BRUNE, B., MESSMER, U. K. AND SANDAU, K.: The role of nitric oxide in cell injury. Toxicol. Lett. 82 83: 233-237, 1995.
14. CATHALA, G., SAVOURET, J.-F., MENDEZ, B., WEST, B. L., KARIN, M., MARTIAL, J. A. AND BAXTER, J. D.: Laboratory methods: A method for isolation of intact, translationally active ribonucleic acid. DNA 2: 329-335, 1983.
15. CHAN, B. M., ELICES, M. J., MURPHY, M. E. AND HEMLER, M. E.: Adhesion to vascular cell adhesion molecule 1 and fibronectin: Comparison of alpha 4 beta 1 (VLA-4) and alpha 4 beta 7 on the human B cell line JY. J. Biol. Chem. 267: 8366-8370, 1992.
16. CIECHANOVER, A.: The ubiquitin-proteasome proteolytic pathway. Cell 79: 13-21, 1994.
17. COGSWELL, J. P., GODLEVSKI, M. M., WISELY, G. B., CLAY, W. C., LEESNITZER, L. M., WAYS, J. P. AND GRAY J. G.: NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J. Immunol. 153: 712-723, 1994.
18. COLLINS, T., READ, M. A., NEISH, A. S., WHITLEY, M. Z., THANOS, D. AND MANIATIS, T.: Transcriptional regulation of endothelial cell adhesion molecules: NFκB and cytokine-inducible enhancers. FASEB J. 9: 899-909, 1995.
19. DE CATERINA, R., LIBBY, P., PENG, H.-B., THANNICKAL, V. J., RAJAVASHISTH, T. B., GIMBRONE, M. A. JR., SHIN, W. S. AND LIAO, J. K.: Nitric oxide decreases cytokine-induced endothetial cell activation: Nitric oxide selectively reduces endothelial cell expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96: 60-68, 1995.
20. ELICES, M. J., OSBORN, L., TAKADA, Y., CROUSE, C., LUBOWSKYJ, S., HEMLER, M. E. AND LOBB, R.: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60: 577-584, 1990.
21. FREUNDLISH, B., BOMALASKI, J. S., NEILSON, E. AND JIMENEZ, S. A.: Regulation of fibroblast proliferation and collagen syntheses by cytokines. Immunol. Today 7: 303-307, 1986.
22. FUKUO, K., HATA, S., SUHARA, T., NAKAHASHI, T., SHINTO, Y., ZYGOMATA, Y., MORIMOTO, S. AND OGIHARA, T.: Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension 27: 823-826, 1996.
23. GOLDBERG, A. L.: The mechanisms and functions of ATP-dependent proteases in bacterial and animal cells. Eur. J. Biochem. 203: 9-23, 1992.
24. GOLDBERG, A. L. AND ROCK, K. L.: Proteolysis, proteasomes and antigen presentation. Nature 357: 375-379, 1992.
25. GOSPODAROWICZ, D., NEUFELD, G. AND SCHWEIGERER, L.: Review: Fibroblast growth factor. Mol. Cell. Endocrinol. 46: 187-204, 1986.
26. GRAHAM, M. F., DIEGELMANN, R. F., ELSON, C. O., LINBLAD, W. J., GOTSCHALK, N., GAY, S. AND GAY, R.: Collagen content and types in strictures of Crohn's disease. Gastroenterology 94: 257-265, 1988.
27. GRISTAVAGE, J. M., WILK, S. AND IGNARRO, L. J.: Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proc. Natl. Acad. Sci. USA 93: 3308-3312, 1996.
28. GRISHAM, M. B., SPECIAN, R. B. AND ZIMMERMAN, T. E.: Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J. Pharmacol. Exp. Ther. 271: 1114-1121, 1994.
29. GRISHAM, M. B., JOHNSON, G. G., GAUTREAUX, M. D. AND BERG, R. D.: Measurement of nitrate and nitrite in extracellular fluids: A window to systemic nitric oxide metabolism. Methods Enzymol. 7: 84-90, 1995.
30. GRISHAM, M. B., DEMICHELE, S. J., GARLEB, K. A. AND SPECIAN, R. D.: Sulfasalazine or enteral diets containing fish oil or oligosaccharides attenuate chronic colitis in rats. Inflam. Bowel Dis. 2: 178-188, 1996.
31. GROTENDORST, G. R.: Growth factors as regulators of wound repair. Int. J. Tissue React. 6: 337-344, 1988.
32. HOGABOAM, C. M., JACOBSON, K., COLLINS, S. M. AND BLENNERHASSETT, M. G.: The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am. J. Physiol. 268: G673-G684, 1995.
33. HOYOS, B., BALLARD, D. W., BOHNLEIN, E., SIEKEVITY, M. AND GREEN, W. C.: Kappa-B specific DNA binding proteins: Role in the regulation of human interleukin-2 gene expression. Science 244: 457-460, 1989.
34. IWASAKI, T., UEHARA, Y., GRAVES, L., RACHIE, N. AND BOMSZTYK, K: Herbimycin A blocks IL-1 induced NFκB DNA-binding activity in lymphoid cell lines. FEBS Lett. 298: 240-244, 1992.
35. KHAN, B. V., HARRISON, D. G., OLBRYCH, M. T., ALEXANDER, R. W. AND MEDFORD, R. M.: Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc. Nat. Acad. Sci. USA 93: 9114-9119, 1996.
36. KING, R. W., PETERS, J. M., TUGENDREICH, S., ROLFE, M., HIETER, P. AND KIRSCHNER, M. W.: A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 81: 279-288, 1995.
37. KOPP, E. AND GHOSH, S.: NFκB and Rel proteins in innate immunity. Adv. Immunol. 58: 1-27, 1994.
38. KUNSCH, C. AND ROSEN, C. A.: NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol. Cell. Biol. 13: 6137-6146, 1993.
39. LIAO, W. S., LU, S. Y., HUANG, J., LI, L. AND BING, Z.: Transcription factors as targets of cytokine signals. Ann. N. Y. Acad. Sci. 762: 238-250, 1995.
40. LIEBERMAN, T. A. AND BALTIMORE, D.: Activation of interleukin-6 gene expression through the NFκB transcription factor. Mol. Cell. Biol. 10: 2327-2334, 1990.
41. MIDDLETON, S. J., SHORTHOUSE, M. AND HUNTER, J. O.: Increased nitric oxide synthesis in ulcerative colitis. Lancet 341: 456-466, 1993.
42. MILLER, M. J. S., SADOWSKA-KROWICKA, H., CHOTINARUEMOL, S., KAKKIS, J. L. AND CLARK, D. A.: Amelioration of chronic ileitis by nitric oxide synthase inhibition. J. Pharmacol. Exp. Ther. 264: 11-16, 1992.
43. MUKAIDA, N., OKAMOTO, S., ISHIKAWA, Y. AND MATSUSHIMA, K.: Molecular mechanism of interleukin-8 gene expression. J. Leukoc. Biol. 56: 554-558, 1994.
44. MULLER, J. M., ZIEGLER-HEITBROCK, H. W. AND BAEUERLE, P. A.: Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187: 233-256, 1993.
45. OSBORN, L., KUNKEL, S. AND NABEL, G. J.: TNF-α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of NF-κB. Proc. Natl. Acad. Sci. USA 86: 2336-2340, 1989.
46. PALOMBELLA, V. J., RANDO, O. J., GOLDBERG, A. L. AND MANIATIS, T.: The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of HF-kappa B. Cell 78: 773-785, 1994.
47. POSTLEWAITE, A. E., KESKI-OJA, J., MOSES, H. L. AND KANG, A. H.: Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J. Exp. Med. 165: 251-256, 1987.
48. RACHMILEWITZ, D., STAMLER, J. S., BACHWICH, D., KARMELI, F., ACKERMAN, Z. AND PODOLSKY, D. K.: Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 36: 718-723, 1995.
49. READ, M. A., NEISH, A. S., LUCINSKAS, F. W., PALOMBELLA, V. J., MANIATIS, T. AND COLLINS, T.: The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 2: 493-506, 1995.
50. REMICK, D. G. AND VILLARETE, L.: Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen metabolites. J. Leukoc. Biol. 59: 471-475, 1996.
51. RIBBONS, K. A., CLARK, D. A., CURRIE, M. G., MOORE, W. M. AND MILLER, M. J. S.: Inducibie nitric oxide synthase and idiopathic colitis in rhesus macaques. Gastroenterology 108: A903, 1995.
52. ROCK, K. L., GRAMM, C., ROTHSTEIN, L., CLARK, K., DICK, L., HWANG, D. AND GOLDBERG, A. L.: Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771, 1994.
53. SAMBROOK, J., FRITSCH, E. F. AND MANIATIS, T.: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
54. SCHRECK, R., ALBERMANN, K. AND BAEUERLE, P. A.: NFκB: An oxidative stress-responsive transcription factor of eukaryotic cells [Review]. Free Radical Res. Commun. 17: 221-237, 1992.
55. SHAKHOV, A. N., COLLART, M. A., VASILLI, P., NEDOSPASOVE, S. A. AND JONGENEEL, C. V.: κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of tumor necrosis factor α gene in primary macrophages. J. Exp. Med. 171: 35-47, 1990.
56. SHIMAOKA, M., IIDA, T., OHARA, A., TAENAKA, N., MASHIMO, T., HONDA, T. AND YOSHIYA, I.: NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophages. Biochem. Biophys. Res. Commun. 209: 519-526, 1995.
57. TRAENCKNER, E. B., WILK, S. AND BAEUERLE, P. A.: A proteasome inhibitor prevents the activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa-B-alpha that is still bound to NF-kappa B. EMBO J. 13: 5433-5441, 1994.
58. XIE, Q.-W., KASHIWABARA, Y. AND NATHAN, C.: Role of the transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269: 4705-4708, 1994.
59. YAGLOM, J., LINSKENS, M. H., SADIS, S., RUBIN, D. M., FUTCHER, B. AND FINLEY, D.: p34Cdc28-mediated control of Cln3 cyclin degradation. Mol. Cell. Biol. 15: 731-741, 1995.
60. YAMADA, T., SARTOR, R. B., MARSHALL, S., SPECIAN, R. D. AND GRISHAM, M. B.: Mucosal injury and inflammation in a model of granulomatous colitis in rats. Gastroenterology 104: 759-777, 1993.